for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Medknow Publishers   (Total: 356 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 356 Journals sorted alphabetically
Advanced Arab Academy of Audio-Vestibulogy J.     Open Access  
Advances in Human Biology     Open Access  
African J. for Infertility and Assisted Conception     Open Access  
African J. of Business Ethics     Open Access   (Followers: 7)
African J. of Medical and Health Sciences     Open Access  
African J. of Paediatric Surgery     Open Access   (Followers: 7, SJR: 0.269, h-index: 10)
African J. of Trauma     Open Access  
Ain-Shams J. of Anaesthesiology     Open Access   (Followers: 3)
Al-Azhar Assiut Medical J.     Open Access  
Al-Basar Intl. J. of Ophthalmology     Open Access  
Ancient Science of Life     Open Access   (Followers: 6)
Anesthesia : Essays and Researches     Open Access   (Followers: 7)
Annals of African Medicine     Open Access   (Followers: 1, SJR: 0.331, h-index: 15)
Annals of Bioanthropology     Open Access   (Followers: 2)
Annals of Cardiac Anaesthesia     Open Access   (Followers: 12, SJR: 0.408, h-index: 15)
Annals of Indian Academy of Neurology     Open Access   (Followers: 3, SJR: 0.308, h-index: 14)
Annals of Maxillofacial Surgery     Open Access   (Followers: 6)
Annals of Medical and Health Sciences Research     Open Access   (Followers: 7)
Annals of Nigerian Medicine     Open Access   (Followers: 1)
Annals of Pediatric Cardiology     Open Access   (Followers: 5, SJR: 0.441, h-index: 10)
Annals of Saudi Medicine     Open Access   (SJR: 0.24, h-index: 29)
Annals of Thoracic Medicine     Open Access   (Followers: 4, SJR: 0.388, h-index: 19)
Annals of Tropical Medicine and Public Health     Open Access   (Followers: 15, SJR: 0.148, h-index: 5)
APOS Trends in Orthodontics     Open Access   (Followers: 1)
Arab J. of Interventional Radiology     Open Access  
Archives of Intl. Surgery     Open Access   (Followers: 9)
Archives of Medicine and Health Sciences     Open Access   (Followers: 2)
Archives of Pharmacy Practice     Open Access   (Followers: 4)
Asia Pacific J. of Clinical Trials : Nervous System Diseases     Open Access  
Asia-Pacific J. of Oncology Nursing     Open Access   (Followers: 3)
Asian J. of Andrology     Open Access   (Followers: 1, SJR: 0.879, h-index: 49)
Asian J. of Neurosurgery     Open Access   (Followers: 2)
Asian J. of Oncology     Open Access   (Followers: 1)
Asian J. of Transfusion Science     Open Access   (Followers: 1, SJR: 0.362, h-index: 10)
Astrocyte     Open Access  
Avicenna J. of Medicine     Open Access   (Followers: 1)
AYU : An international quarterly journal of research in Ayurveda     Open Access   (Followers: 6)
Benha Medical J.     Open Access  
BLDE University J. of Health Sciences     Open Access  
Brain Circulation     Open Access   (Followers: 1)
Bulletin of Faculty of Physical Therapy     Open Access  
Cancer Translational Medicine     Open Access   (Followers: 1)
CHRISMED J. of Health and Research     Open Access  
Clinical Dermatology Review     Open Access  
Clinical Trials in Degenerative Diseases     Open Access  
Clinical Trials in Orthopedic Disorders     Open Access  
Community Acquired Infection     Open Access  
Conservation and Society     Open Access   (Followers: 10, SJR: 0.82, h-index: 12)
Contemporary Clinical Dentistry     Open Access   (Followers: 4)
Current Medical Issues     Open Access  
CytoJ.     Open Access   (Followers: 2, SJR: 0.339, h-index: 19)
Delta J. of Ophthalmology     Open Access  
Dental Hypotheses     Open Access   (Followers: 3, SJR: 0.131, h-index: 4)
Dental Research J.     Open Access   (Followers: 9)
Dentistry and Medical Research     Open Access  
Digital Medicine     Open Access  
Drug Development and Therapeutics     Open Access  
Education for Health     Open Access   (Followers: 4, SJR: 0.205, h-index: 22)
Egyptian J. of Bronchology     Open Access  
Egyptian J. of Cardiothoracic Anesthesia     Open Access  
Egyptian J. of Cataract and Refractive Surgery     Open Access   (Followers: 1)
Egyptian J. of Dermatology and Venerology     Open Access  
Egyptian J. of Haematology     Open Access  
Egyptian J. of Internal Medicine     Open Access  
Egyptian J. of Neurology, Psychiatry and Neurosurgery     Open Access   (Followers: 1, SJR: 0.121, h-index: 3)
Egyptian J. of Obesity, Diabetes and Endocrinology     Open Access  
Egyptian J. of Otolaryngology     Open Access  
Egyptian J. of Psychiatry     Open Access   (Followers: 2)
Egyptian J. of Surgery     Open Access   (Followers: 1)
Egyptian Orthopaedic J.     Open Access  
Egyptian Pharmaceutical J.     Open Access  
Egyptian Retina J.     Open Access  
Egyptian Rheumatology and Rehabilitation     Open Access  
Endodontology     Open Access  
Endoscopic Ultrasound     Open Access   (SJR: 0.473, h-index: 8)
Environmental Disease     Open Access  
European J. of Dentistry     Open Access   (Followers: 2, SJR: 0.496, h-index: 11)
European J. of General Dentistry     Open Access   (Followers: 1)
European J. of Prosthodontics     Open Access   (Followers: 2)
European J. of Psychology and Educational Studies     Open Access   (Followers: 6)
Fertility Science and Research     Open Access  
Formosan J. of Surgery     Open Access   (SJR: 0.107, h-index: 5)
Genome Integrity     Open Access   (Followers: 4, SJR: 1.227, h-index: 12)
Global J. of Transfusion Medicine     Open Access  
Heart India     Open Access  
Heart Views     Open Access  
Hepatitis B Annual     Open Access   (Followers: 3)
IJS Short Reports     Open Access  
Indian Anaesthetists Forum     Open Access  
Indian Dermatology Online J.     Open Access   (Followers: 2)
Indian J. of Allergy, Asthma and Immunology     Open Access   (Followers: 1)
Indian J. of Anaesthesia     Open Access   (Followers: 7, SJR: 0.302, h-index: 13)
Indian J. of Burns     Open Access   (Followers: 1)
Indian J. of Cancer     Open Access   (SJR: 0.318, h-index: 26)
Indian J. of Cerebral Palsy     Open Access  
Indian J. of Community Medicine     Open Access   (Followers: 2, SJR: 0.618, h-index: 16)
Indian J. of Critical Care Medicine     Open Access   (Followers: 1, SJR: 0.307, h-index: 16)
Indian J. of Dental Research     Open Access   (Followers: 4, SJR: 0.243, h-index: 24)
Indian J. of Dental Sciences     Open Access  
Indian J. of Dentistry     Open Access   (Followers: 1)
Indian J. of Dermatology     Open Access   (Followers: 2, SJR: 0.448, h-index: 16)
Indian J. of Dermatology, Venereology and Leprology     Open Access   (Followers: 2, SJR: 0.563, h-index: 29)
Indian J. of Dermatopathology and Diagnostic Dermatology     Open Access  
Indian J. of Drugs in Dermatology     Open Access  
Indian J. of Endocrinology and Metabolism     Open Access   (Followers: 4)
Indian J. of Health Sciences     Open Access   (Followers: 1)
Indian J. of Medical and Paediatric Oncology     Open Access   (SJR: 0.292, h-index: 9)
Indian J. of Medical Microbiology     Open Access   (Followers: 1, SJR: 0.53, h-index: 34)
Indian J. of Medical Research     Open Access   (Followers: 4, SJR: 0.716, h-index: 60)
Indian J. of Medical Sciences     Open Access   (Followers: 2, SJR: 0.207, h-index: 31)
Indian J. of Multidisciplinary Dentistry     Open Access   (Followers: 1)
Indian J. of Nephrology     Open Access   (Followers: 1, SJR: 0.233, h-index: 12)
Indian J. of Nuclear Medicine     Open Access   (Followers: 2, SJR: 0.213, h-index: 5)
Indian J. of Occupational and Environmental Medicine     Open Access   (Followers: 4, SJR: 0.203, h-index: 13)
Indian J. of Ophthalmology     Open Access   (Followers: 4, SJR: 0.536, h-index: 34)
Indian J. of Oral Health and Research     Open Access  
Indian J. of Oral Sciences     Open Access   (Followers: 1)
Indian J. of Orthopaedics     Open Access   (Followers: 9, SJR: 0.393, h-index: 15)
Indian J. of Otology     Open Access   (Followers: 1, SJR: 0.218, h-index: 5)
Indian J. of Paediatric Dermatology     Open Access   (Followers: 1)
Indian J. of Pain     Open Access   (Followers: 1)
Indian J. of Palliative Care     Open Access   (Followers: 5, SJR: 0.35, h-index: 12)
Indian J. of Pathology and Microbiology     Open Access   (Followers: 1, SJR: 0.285, h-index: 22)
Indian J. of Pharmacology     Open Access   (SJR: 0.347, h-index: 44)
Indian J. of Plastic Surgery     Open Access   (Followers: 12, SJR: 0.303, h-index: 13)
Indian J. of Psychiatry     Open Access   (Followers: 3, SJR: 0.496, h-index: 15)
Indian J. of Psychological Medicine     Open Access   (Followers: 1, SJR: 0.344, h-index: 9)
Indian J. of Public Health     Open Access   (Followers: 1, SJR: 0.444, h-index: 17)
Indian J. of Radiology and Imaging     Open Access   (Followers: 4, SJR: 0.253, h-index: 14)
Indian J. of Research in Homoeopathy     Open Access  
Indian J. of Rheumatology     Open Access   (SJR: 0.169, h-index: 7)
Indian J. of Sexually Transmitted Diseases and AIDS     Open Access   (Followers: 2, SJR: 0.313, h-index: 9)
Indian J. of Social Psychiatry     Open Access   (Followers: 2)
Indian J. of Urology     Open Access   (Followers: 3, SJR: 0.366, h-index: 16)
Indian J. of Vascular and Endovascular Surgery     Open Access   (Followers: 2)
Industrial Psychiatry J.     Open Access   (Followers: 2)
Intl. J. of Academic Medicine     Open Access  
Intl. J. of Advanced Medical and Health Research     Open Access  
Intl. J. of Applied and Basic Medical Research     Open Access  
Intl. J. of Clinical and Experimental Physiology     Open Access   (Followers: 1)
Intl. J. of Critical Illness and Injury Science     Open Access  
Intl. J. of Educational and Psychological Researches     Open Access   (Followers: 2)
Intl. J. of Environmental Health Engineering     Open Access   (Followers: 1)
Intl. J. of Forensic Odontology     Open Access   (Followers: 1)
Intl. J. of Green Pharmacy     Open Access   (Followers: 4, SJR: 0.229, h-index: 13)
Intl. J. of Health & Allied Sciences     Open Access   (Followers: 1)
Intl. J. of Health System and Disaster Management     Open Access   (Followers: 2)
Intl. J. of Heart Rhythm     Open Access  
Intl. J. of Medicine and Public Health     Open Access   (Followers: 7)
Intl. J. of Mycobacteriology     Open Access   (SJR: 0.239, h-index: 4)
Intl. J. of Noncommunicable Diseases     Open Access  
Intl. J. of Nutrition, Pharmacology, Neurological Diseases     Open Access   (Followers: 4)
Intl. J. of Oral Health Sciences     Open Access   (Followers: 1)
Intl. J. of Orthodontic Rehabilitation     Open Access  
Intl. J. of Pedodontic Rehabilitation     Open Access  
Intl. J. of Pharmaceutical Investigation     Open Access   (Followers: 1)
Intl. J. of Preventive Medicine     Open Access   (Followers: 1, SJR: 0.523, h-index: 15)
Intl. J. of Shoulder Surgery     Open Access   (Followers: 6, SJR: 0.611, h-index: 9)
Intl. J. of Trichology     Open Access   (SJR: 0.37, h-index: 10)
Intl. J. of Yoga     Open Access   (Followers: 15)
Intl. J. of Yoga : Philosophy, Psychology and Parapsychology     Open Access   (Followers: 6)
Iranian J. of Nursing and Midwifery Research     Open Access   (Followers: 2)
Iraqi J. of Hematology     Open Access  
J. of Academy of Medical Sciences     Open Access  
J. of Advanced Pharmaceutical Technology & Research     Open Access   (Followers: 4, SJR: 0.427, h-index: 15)
J. of Anaesthesiology Clinical Pharmacology     Open Access   (Followers: 8, SJR: 0.416, h-index: 14)
J. of Applied Hematology     Open Access  
J. of Association of Chest Physicians     Open Access   (Followers: 2)
J. of Basic and Clinical Reproductive Sciences     Open Access   (Followers: 1)
J. of Cancer Research and Therapeutics     Open Access   (Followers: 4, SJR: 0.359, h-index: 21)
J. of Carcinogenesis     Open Access   (Followers: 1, SJR: 1.152, h-index: 26)
J. of Cardiothoracic Trauma     Open Access  
J. of Cardiovascular Disease Research     Open Access   (Followers: 3, SJR: 0.351, h-index: 13)
J. of Cardiovascular Echography     Open Access   (SJR: 0.134, h-index: 2)
J. of Cleft Lip Palate and Craniofacial Anomalies     Open Access   (Followers: 2)
J. of Clinical and Preventive Cardiology     Open Access  
J. of Clinical Imaging Science     Open Access   (Followers: 1, SJR: 0.277, h-index: 8)
J. of Clinical Neonatology     Open Access   (Followers: 1)
J. of Clinical Ophthalmology and Research     Open Access   (Followers: 1)
J. of Clinical Sciences     Open Access  
J. of Conservative Dentistry     Open Access   (Followers: 4, SJR: 0.532, h-index: 10)
J. of Craniovertebral Junction and Spine     Open Access   (Followers: 4, SJR: 0.199, h-index: 9)
J. of Current Medical Research and Practice     Open Access  
J. of Current Research in Scientific Medicine     Open Access  
J. of Cutaneous and Aesthetic Surgery     Open Access   (Followers: 1)
J. of Cytology     Open Access   (Followers: 1, SJR: 0.274, h-index: 9)
J. of Dental and Allied Sciences     Open Access   (Followers: 1)
J. of Dental Implants     Open Access   (Followers: 7)
J. of Dental Lasers     Open Access   (Followers: 2)
J. of Dental Research and Review     Open Access   (Followers: 1)
J. of Digestive Endoscopy     Open Access   (Followers: 3)
J. of Dr. NTR University of Health Sciences     Open Access  
J. of Earth, Environment and Health Sciences     Open Access   (Followers: 1)
J. of Education and Ethics in Dentistry     Open Access   (Followers: 5)
J. of Education and Health Promotion     Open Access   (Followers: 5)
J. of Emergencies, Trauma and Shock     Open Access   (Followers: 8, SJR: 0.353, h-index: 14)
J. of Engineering and Technology     Open Access   (Followers: 6)
J. of Experimental and Clinical Anatomy     Open Access   (Followers: 2)
J. of Family and Community Medicine     Open Access  
J. of Family Medicine and Primary Care     Open Access   (Followers: 8)

        1 2 | Last   [Sort by number of followers]   [Restore default list]

Journal Cover Indian Journal of Dermatology, Venereology and Leprology
  [SJR: 0.563]   [H-I: 29]   [2 followers]  Follow
    
  This is an Open Access Journal Open Access journal
   ISSN (Print) 0378-6323 - ISSN (Online) 0973-3922
   Published by Medknow Publishers Homepage  [356 journals]
  • The menace of dermatophytosis in India: The evidence that we need

    • Authors: Saumya Panda, Shyam Verma
      Pages: 281 - 284
      Abstract: Saumya Panda, Shyam Verma
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):281-284

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):281-284
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_224_17
      Issue No: Vol. 83, No. 3 (2017)
       
  • Seborrheic melanosis: An entity worthy of mention in dermatological
           literature

    • Authors: Shyam B Verma, Resham J Vasani, Laxmisha Chandrashekar, Mary Thomas
      Pages: 285 - 289
      Abstract: Shyam B Verma, Resham J Vasani, Laxmisha Chandrashekar, Mary Thomas
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):285-289

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):285-289
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.203248
      Issue No: Vol. 83, No. 3 (2017)
       
  • Autophagy: A brief overview in perspective of dermatology

    • Authors: Rahul Nagar
      Pages: 290 - 297
      Abstract: Rahul Nagar
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):290-297
      Autophagy, literally meaning “self-eating,” is an intracellular catabolic process of delivering cytosol and/or its specific content to the lysosomes for degradation.The resulting macromolecular constituents are recycled and utilized again by the cells. Basal level autophagy plays an important role in cellular homeostasis through the elimination of the old or damaged organelles, as well as aggregated intracellular proteins. Autophagy refers to sequestration of intact organelles along with a portion of cytosol, into a double-or multi-membrane structure known as phagophore, which elongates, and after closure, forms a vesicular structure known as the autophagosome. Subsequently, the mature autophagosome fuses with a lysosome, thereby forming a single membrane structure, an autolysosome. Autophagy plays a critical role in inflammation, autoimmunity and cellular differentiation. Skin serves as the first line of defense against a variety of environmental insults and autophagy is thought to be a form of an endogenous defense mechanism against such environmental derangements. Autophagy has been linked with keratinocyte differentiation and melanocyte survival, as well as with the pathogenesis of diverse skin disorders including systemic lupus erythematosus, systemic sclerosis, psoriasis, vitiligo, infectious skin diseases and cancer. Autophagy has been one of the most studied phenomena in cell biology and pathophysiology, and given its broad clinical implications, has become a major target for drug discovery. The last decade has seen a substantial upsurge in autophagy-related research and publications; still, the dermatology literature appears to be less initiated. Autophagy will probably change our understanding of dermatological disorders/medicines. Hence, a basic knowledge of autophagy is a prerequisite to understand the developments in the field of autophagy-related research.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):290-297
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.196320
      Issue No: Vol. 83, No. 3 (2017)
       
  • Update on etiopathogenesis and treatment of Acne

    • Authors: Yasmeen Jabeen Bhat, Insha Latief, Iffat Hassan
      Pages: 298 - 306
      Abstract: Yasmeen Jabeen Bhat, Insha Latief, Iffat Hassan
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):298-306
      Acne, the most common skin disease, is a disorder of pilosebaceous units that affects adolescents mainly and adults occasionally. The pathogenesis is multifactorial. Besides genetic predisposition, other major factors include the action of androgens, pro-inflammatory lipids acting as ligands of peroxisome proliferator-activated receptors in the sebocytes, toll-like receptor-2 acting on keratinocytes, recognition of pathogen-associated molecular patterns, cytokines, chemokines, inflammasomes, neuroendocrine regulatory mechanisms, diet and other pro-inflammatory targets implicated in the activation of immune detection and response. Most of these factors converge on mammalian target of rapamycin complex1 (mTORC1) activation which is further enhanced by the nutrient signaling of Western diet. This multitude of pathogenic factors has led to a new armamentarium of drugs for the treatment of acne. Topical anti-androgens, insulin-like growth factor-1 inhibitors, peroxisome proliferator-activated receptor-modulators, acetylcholine inhibitors, topical retinoic acid metabolism-blocking agents, vitamin D analogues, antimicrobial peptides, interleukin-1α and interleukin-1β blockers and immunotherapy are some of the novel treatment options.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):298-306
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.199581
      Issue No: Vol. 83, No. 3 (2017)
       
  • Digital volumetric measurement of cutaneous leishmaniasis lesions: Blur
           estimation method

    • Authors: Ahmad Reza Taheri, Saeid Alikhani, Ameneh Sazgarnia, Maryam Salehi, Sadegh Vahabi Amlashi
      Pages: 307 - 311
      Abstract: Ahmad Reza Taheri, Saeid Alikhani, Ameneh Sazgarnia, Maryam Salehi, Sadegh Vahabi Amlashi
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):307-311
      Background: Cutaneous leishmaniasis is a common parasitic infestation in Iran. With recent advantages in digital imaging, we have devised a novel non-contact objective method of measuring lesions.Aim: The aim of the study was to design a software system that analyzes images of cutaneous leishmaniasis lesions, objectively assess and monitor volume.Methods: A photographic technique along with an image processing algorithm was applied to extract a three-dimensional map of the lesion from a simple two-dimensional picture. This method recovers depth on the basis of blur estimation. A macro lens with a low depth of field was used to blur the objects out of focus. To assess and compare the results, a polymer mold of the corresponding lesion was made and filled with liquid. The volume of liquid corresponded to the volume of the lesion. A total of thirty-seven patients were enrolled, and 48 lesions were analyzed.Results: The mean volume measured by image processing was 159 μl (range: 8–685 μl), in comparison to an average of 170 μl (range: 6–800 μl) obtained from the molds. This was not significantly different. Statistical analysis by the Pearson correlation test showed a 'very good fit' correlation between these measured volumes (P < 0.001, r = 0.938).Limitation: The location and height of lesions were two important limitations in implementing this technique. If the lesion location is in the curvature region of body or the lesion height is less than 1 mm or more than 1 cm, this method will lose precision and accuracy.Conclusion: Image processing with blur estimation technique is an accurate and precise method to measure the volume of lesions in cutaneous leishmaniasis.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):307-311
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_134_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Effectiveness, safety and tolerability of cyclosporine versus supportive
           treatment in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A
           record-based study

    • Authors: Swosti Mohanty, Anupam Das, Anupama Ghosh, Amrita Sil, Ramesh Chandra Gharami, Debabrata Bandyopadhyay, Nilay Kanti Das
      Pages: 312 - 316
      Abstract: Swosti Mohanty, Anupam Das, Anupama Ghosh, Amrita Sil, Ramesh Chandra Gharami, Debabrata Bandyopadhyay, Nilay Kanti Das
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):312-316
      Background: Toxic epidermal necrolysis and Stevens–Johnson syndrome comprise life-threatening, drug-induced mucocutaneous disease spectrum. Interest in cyclosporine, a calcineurin inhibitor that can block the function of T-cells, has increased with the discovery of the importance of granulysin in apoptosis in toxic epidermal necrolysis. In our hospital, cyclosporine is given to Stevens–Johnson syndrome/toxic epidermal necrolysis patients as an adjunctive therapy.Aims: This study is an observational, record-based study comparing the effectiveness and safety of patients receiving cyclosporine versus only supportive therapy.Methodology: Medical records as bed-head tickets and laboratory investigation reports of Stevens–Johnson syndrome/toxic epidermal necrolysis patients admitted in the hospital over a period of 1 year were collected. Data regarding clinico-demographic profile, suspected drug causing Stevens–Johnson's syndrome/toxic epidermal necrolysis, SCORTEN, body surface area involved, treatment received and outcome were obtained.Results: Twenty-eight patients were analyzed. Nineteen belonged to the cyclosporine group (supportive treatment + cyclosporine), nine to supportive treatment only group. Among the suspected drugs, antiepileptics formed the major group (28.6%). Five patients in the supportive only group and one in the cyclosporine group died. Time for stabilization and reepithelialization and duration of recovery were significantly lower in the cyclosporine group (P < 0.001, P= 0.007, P= 0.01, respectively). The standardized mortality ratio was 0.32 in cyclosporine group which is nearly 3.3 times lower than the only supportive treatment.Limitations: As it was a record-based study, certain confounding factors (serum blood urea nitrogen) could not be adjusted.Conclusion: Cyclosporine (5 mg/kg/day) for 10 days from onset of Stevens–Johnson syndrome/toxic epidermal necrolysis may decrease the risk of dying, may provide faster healing of lesions and might lead to early discharge from hospital.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):312-316
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_201_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Low-dose rituximab as an adjuvant therapy in pemphigus

    • Authors: Jaya Gupta, Ranjan C Raval, Arti N Shah, Rekha B Solanki, Dhara D Patel, Kaksha B Shah, Ami D Badheka, Keyur B Shah, Neetish K Aggarwal, Vaaruni Ravishankar
      Pages: 317 - 325
      Abstract: Jaya Gupta, Ranjan C Raval, Arti N Shah, Rekha B Solanki, Dhara D Patel, Kaksha B Shah, Ami D Badheka, Keyur B Shah, Neetish K Aggarwal, Vaaruni Ravishankar
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):317-325
      Background: Pemphigus is a chronic autoimmune blistering disease where systemic steroids and immunosuppressants are the mainstay of therapy, but long-term treatment with these agents is associated with many side effects. Rituximab, a chimeric monoclonal anti-CD20 antibody, in low doses has shown efficacy as an adjuvant to reduce the dose of steroids.Aim: To study the clinical efficacy and safety of low-dose rituximab as an adjuvant therapy in pemphigus.Methods: Fifty patients with extensive pemphigus were selected, who either had recalcitrant pemphigus, were steroid dependent, had relapsed after pulse therapy, had anti-desmoglein levels >20, had contraindications to conventional treatment or wanted to avoid conventional treatment and its side effects. Two doses of rituximab (500 mg) were given 2 weeks apart and patients were regularly followed up every 2 weeks for 3 months and then monthly upto 2 years. Complete blood counts, liver function tests, renal function tests, skin biopsy, direct immunofluorescence and desmoglein levels were checked before and after rituximab administration. Pre-rituximab chest X-ray and electrocardiograph were also obtained.Results: At 3 months, 41 (82%) patients showed complete remission. Nine (18%) patients had partial remission. After 6–12 months, 20 (40% of enrolled patients) continued to be in remission and were off all systemic therapy and the remaining 19 (38%) were continuing to take low doses of steroids with or without other adjuvant immunosuppressants and 2 (4%) had to be given another 2 doses of rituximab and subsequently could be managed with low-dose steroids. Of the 9 patients in partial remission at 3 months, after 6–12 months 5 (10% of the total) were completely off treatment and went into complete remission and 4 (8%) were on additional treatment out of which 2 (4%) had to be given 2 additional doses of rituximab and were in partial remission with low-dose therapy at the end of 12 months. One patient developed urticaria as a side effect. Another developed herpes zoster.Conclusion: Our results show that low-dose rituximab is a well-tolerated and beneficial adjuvant therapy in recalcitrant pemphigus which helps reduce both the severity of disease as well as the dose of steroids and immunosuppressants.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):317-325
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_1078_14
      Issue No: Vol. 83, No. 3 (2017)
       
  • Clinico-epidemiological study of tinea incognito with microbiological
           correlation

    • Authors: Bornali Dutta, Elmy Samsul Rasul, Bobita Boro
      Pages: 326 - 331
      Abstract: Bornali Dutta, Elmy Samsul Rasul, Bobita Boro
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):326-331
      Background: Tinea incognito is a dermatophytic infection with a clinical presentation that is modified due to previous treatment with topical or systemic steroids, as well as topical immunomodulators. It tends to mimic other dermatological conditions.Aims: To evaluate the various clinical manifestations, sites, predisposing factors and causative agents of tinea incognito.Methods: A prospective observational study was done on one hundred clinically suspected cases of tinea incognito, with a history of topical or systemic steroid use for a period of at least six weeks. They were subject to direct microscopy and fungal culture, and re-evaluated at the end of the third and sixth week.Results: Eczema-like conditions were the most common clinical manifestation, followed by inflammatory, autoimmune and infective conditions. The face was the most commonly affected site. Direct microscopy was positive in 85% of cases, and fungal culture was positive in 63% of cases. Trichophyton rubrum was the most common species isolated. Pharmacists were responsible for 78% of tinea incognito cases, and betamethasone dipropionate was the most common drug used.Limitations: As this was a hospital outpatient-based study, cases with severe systemic problems could have attended other departments. Cases involving the hair and nails were negligible.Conclusions: Tinea incognito is a commonly encountered, yet poorly reported entity in the study population. An increased level of awareness and vigilance on the sale of steroid containing compounds will help control this dermatological condition.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):326-331
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_297_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Successful treatment of Rosai&#8211;Dorfman disease using in situ
           photoimmunotherapy

    • Authors: Meng Li, Lei Shi, Min Luo, Jia Chen, Bo Wang, Fuhe Zhang, Uma Keyal, Anil Kumar Bhatta, Wei R Chen, Xiuli Wang
      Pages: 332 - 336
      Abstract: Meng Li, Lei Shi, Min Luo, Jia Chen, Bo Wang, Fuhe Zhang, Uma Keyal, Anil Kumar Bhatta, Wei R Chen, Xiuli Wang
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):332-336
      Rosai–Dorfman disease is difficult to cure. In situ photoimmunotherapy combines local photothermal therapy with immunoadjuvant. In the present case report, a 39-year-old Chinese man with Rosai–Dorfman disease lesions below the left nostril and left preauricular region was treated with in situ photoimmunotherapy. The patient was treated with daily application of topical imiquimod (5%) and laser irradiations every 2 weeks for 8 weeks. After three cycles of treatment, the lesions improved markedly without adverse effects. Our results showed that in situ photoimmunotherapy can be used as an effective treatment for Rosai–Dorfman disease.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):332-336
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_356_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Clinical characteristics of acquired ungual fibrokeratoma

    • Authors: Sewon Hwang, Miri Kim, Baik Kee Cho, Hyun Jeong Park
      Pages: 337 - 343
      Abstract: Sewon Hwang, Miri Kim, Baik Kee Cho, Hyun Jeong Park
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):337-343
      Background: Acquired ungual fibrokeratomas are uncommon fibrous tissue tumors located in the ungual area. Though there are many reports of this entity, only some reports have reviewed the clinical features of the tumor.Aims: The aim of this study was to clarify the clinical characteristics of acquired ungual fibrokeratomas. Methods: We reviewed twenty patients who were treated surgically at our clinic from 2003 to 2014 for acquired ungual fibrokeratomas confirmed on histopathological examination. Our study was conducted by retrospective analysis of charts, clinical pictures and patient records. Cases of tuberous sclerosis were not included.Results: Acquired ungual fibrokeratomas occurred on toenails in 16 (80%) patients and on fingernails in 4 (20%) patients. Periungual lesions were noted in 15 (75%) patients followed by intraungual lesions in 4 (20%) patients and subungual lesions in 1 (5%) patient. A longitudinal groove was observed in 80% of patients. Surgical resection was performed in all cases for both medical and cosmetic reasons. After excision, recurrence occurred in three cases.Limitations: This was a retrospective study of a limited number of patients.Conclusions: Acquired ungual fibrokeratomas occurred more commonly on toenails than on fingernails and were located in the periungual area in most patients. A longitudinal groove in the nail plate was a frequent finding. Surgical resection led to medical and cosmetic improvement with a recurrence in 3 (15%) patients.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):337-343
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.193611
      Issue No: Vol. 83, No. 3 (2017)
       
  • Tinea pseudoimbricata

    • Authors: Shyam Verma
      Pages: 344 - 345
      Abstract: Shyam Verma
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):344-345

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):344-345
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.187686
      Issue No: Vol. 83, No. 3 (2017)
       
  • Subcutaneous Saksenaea vasiformis infection presenting as disfiguring
           facial plaques

    • Authors: Jantakan Nitinawarat, Opass Putcharoen, Ariya Chindamporn, Pawinee Rerknimitr
      Pages: 346 - 348
      Abstract: Jantakan Nitinawarat, Opass Putcharoen, Ariya Chindamporn, Pawinee Rerknimitr
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):346-348

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):346-348
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_637_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Post-lower segment cesarean section wound infection with Mycobacterium
           abscessus

    • Authors: Chinnu Sasikumar, Unnati Desai, Jyotsna M Joshi
      Pages: 349 - 350
      Abstract: Chinnu Sasikumar, Unnati Desai, Jyotsna M Joshi
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):349-350

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):349-350
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_693_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Myiasis in a neglected case of generalized erythrodermic pemphigus
           foliaceus

    • Authors: Priyanka Patil, Uddhao Zambare, Swagata Tambe, Rashmi Aderao, Chitra Nayak
      Pages: 350 - 352
      Abstract: Priyanka Patil, Uddhao Zambare, Swagata Tambe, Rashmi Aderao, Chitra Nayak
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):350-352

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):350-352
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_503_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Carcinoma erysipeloides due to primary cutaneous squamous cell carcinoma

    • Authors: Suchismita Paul, Elizabeth Yim, Xiaolong Zhou, Erin Wei, Jeong Hee Cho-Vega, Clara Milikowski, Francisco Kerdel
      Pages: 353 - 354
      Abstract: Suchismita Paul, Elizabeth Yim, Xiaolong Zhou, Erin Wei, Jeong Hee Cho-Vega, Clara Milikowski, Francisco Kerdel
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):353-354

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):353-354
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_1078_15
      Issue No: Vol. 83, No. 3 (2017)
       
  • Extrafacial lupus miliaris disseminatus faciei: A rare entity

    • Authors: Yogesh Namdev Kalyanpad, Atul Madhusudan Dongre, Prachi Vinayak Gole, Uday Sharadchandra Khopkar
      Pages: 354 - 357
      Abstract: Yogesh Namdev Kalyanpad, Atul Madhusudan Dongre, Prachi Vinayak Gole, Uday Sharadchandra Khopkar
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):354-357

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):354-357
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.203584
      Issue No: Vol. 83, No. 3 (2017)
       
  • Penile tuberculosis: A case report

    • Authors: Sema Aytekin, Fatih G&#246;ktay, &#350;irin Yasar, Zeynep Altan Ferhato&#487;lu, Pembeg&#252;l G&#252;ne&#351;
      Pages: 357 - 359
      Abstract: Sema Aytekin, Fatih Göktay, Şirin Yasar, Zeynep Altan Ferhatoǧlu, Pembegül Güneş
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):357-359

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):357-359
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_301_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Massive retiform hemangioendothelioma that expresses D2-40

    • Authors: Yang Tan, Yudong Hu, Jinjin Wu, Qionghui Cheng, Xia Lei
      Pages: 360 - 363
      Abstract: Yang Tan, Yudong Hu, Jinjin Wu, Qionghui Cheng, Xia Lei
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):360-363

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):360-363
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_373_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Squamous cell carcinoma in long-standing chromoblastomycosis

    • Authors: Prasenjeet Mohanty, K Vivekanandh, Liza Mohapatra, Gaurav Dash
      Pages: 363 - 365
      Abstract: Prasenjeet Mohanty, K Vivekanandh, Liza Mohapatra, Gaurav Dash
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):363-365

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):363-365
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.201339
      Issue No: Vol. 83, No. 3 (2017)
       
  • Rare case of herpes zoster ophthalmicus with orbital myositis, oculomotor
           nerve palsy and anterior uveitis

    • Authors: Mansha Daswani, Nidhi Bhosale, Virna M Shah
      Pages: 365 - 367
      Abstract: Mansha Daswani, Nidhi Bhosale, Virna M Shah
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):365-367

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):365-367
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.199582
      Issue No: Vol. 83, No. 3 (2017)
       
  • Verrucous eccrine angiomatous hamartoma

    • Authors: Prashant Verma, M Kaur, V Narula, V Ramesh, A Singh, AK Saxena
      Pages: 367 - 369
      Abstract: Prashant Verma, M Kaur, V Narula, V Ramesh, A Singh, AK Saxena
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):367-369

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):367-369
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.197391
      Issue No: Vol. 83, No. 3 (2017)
       
  • Unilateral monomorphic hypopigmented macules: A variant of Darier disease

    • Authors: Jagdish Sakhiya, Neha C Virmani, Yugal K Sharma, Uday Khopkar, Shamsudheen Karuthedath Vellarikkal
      Pages: 369 - 371
      Abstract: Jagdish Sakhiya, Neha C Virmani, Yugal K Sharma, Uday Khopkar, Shamsudheen Karuthedath Vellarikkal
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):369-371

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):369-371
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.199580
      Issue No: Vol. 83, No. 3 (2017)
       
  • Human herpesvirus-8 and human cytomegalovirus infections in Bowen's
           disease: Is there any association?

    • Authors: Fahimeh Abdollahimajd, Hamideh Moravvej, Arian Rashidi, Saeed Aref, Zahra Safaei-Naraghi
      Pages: 372 - 373
      Abstract: Fahimeh Abdollahimajd, Hamideh Moravvej, Arian Rashidi, Saeed Aref, Zahra Safaei-Naraghi
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):372-373

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):372-373
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_179_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Leaving a mark: Multiple geometric areas of alopecia

    • Authors: Hima Gopinath, Maria Kuruvila, Ramadas Naik, Suja Sreedharan
      Pages: 373 - 375
      Abstract: Hima Gopinath, Maria Kuruvila, Ramadas Naik, Suja Sreedharan
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):373-375

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):373-375
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_234_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Ipsilateral facial paralysis and steroid acne

    • Authors: Berna Aksoy
      Pages: 376 - 378
      Abstract: Berna Aksoy
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):376-378

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):376-378
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_363_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Clear cell papulosis: A case report and its possible association with
           epidermal immature dendritic cells

    • Authors: Jae Hwa Kim, Kyung Eun Jung, Dae Won Koo, Joong Sun Lee
      Pages: 379 - 381
      Abstract: Jae Hwa Kim, Kyung Eun Jung, Dae Won Koo, Joong Sun Lee
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):379-381

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):379-381
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_1231_15
      Issue No: Vol. 83, No. 3 (2017)
       
  • Strongyloides stercoralis hyperinfection: An often missed but potentially
           fatal cause of anemia and hypoalbuminemia in leprosy patients on long-term
           steroid therapy

    • Authors: Vishal Gupta, Saurabh Bhatia, Asit Ranjan Mridha, Prasenjit Das, Neena Khanna
      Pages: 381 - 383
      Abstract: Vishal Gupta, Saurabh Bhatia, Asit Ranjan Mridha, Prasenjit Das, Neena Khanna
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):381-383

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):381-383
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_347_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Dermatoscopic evaluation of three cases of nevus lipomatosus cutaneous
           superficialis

    • Authors: Keshavamurthy Vinay, Gitesh U Sawatkar, Uma Nahar Saikia, Muthu Sendhil Kumaran
      Pages: 383 - 386
      Abstract: Keshavamurthy Vinay, Gitesh U Sawatkar, Uma Nahar Saikia, Muthu Sendhil Kumaran
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):383-386

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):383-386
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_677_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Treatment of primary palmar hyperhidrosis using glycopyrrolate
           iontophoresis: Intensity of electrical current used, efficacy and side
           effects

    • Authors: Mabel Qi He Leow, Hong Liang Tey
      Pages: 387 - 388
      Abstract: Mabel Qi He Leow, Hong Liang Tey
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):387-388

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):387-388
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.201338
      Issue No: Vol. 83, No. 3 (2017)
       
  • A combination of oral azathioprine and methotrexate in difficult to treat
           dermatoses

    • Authors: Puneet Agarwal, Uma Shankar Agarwal, Ram Singh Meena, Priyanka Sharma
      Pages: 389 - 392
      Abstract: Puneet Agarwal, Uma Shankar Agarwal, Ram Singh Meena, Priyanka Sharma
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):389-392

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):389-392
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_487_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Response of superimposed linear psoriasis to ustekinumab: A case report

    • Authors: Hao-Jui Weng, Tsen-Fang Tsai
      Pages: 392 - 396
      Abstract: Hao-Jui Weng, Tsen-Fang Tsai
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):392-396

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):392-396
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.203080
      Issue No: Vol. 83, No. 3 (2017)
       
  • Scrotal lymphangiectasia following scrofuloderma

    • Authors: Debabrata Bandyopadhyay
      Pages: 397 - 398
      Abstract: Debabrata Bandyopadhyay
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):397-398

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):397-398
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.201340
      Issue No: Vol. 83, No. 3 (2017)
       
  • Beta-blockers in dermatology

    • Authors: Neel Prabha, Namrata Chhabra, Ripudaman Arora
      Pages: 399 - 407
      Abstract: Neel Prabha, Namrata Chhabra, Ripudaman Arora
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):399-407

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):399-407
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_220_16
      Issue No: Vol. 83, No. 3 (2017)
       
  • Unusual targetoid nodule on the back

    • Authors: Isidora García-Huidobro, Alvaro &#193;barz&#250;a-Araya, Camila Downey, Sergio Gonz&#225;lez
      Pages: 408 - 410
      Abstract: Isidora García-Huidobro, Alvaro Ábarzúa-Araya, Camila Downey, Sergio González
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):408-410

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):408-410
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.190874
      Issue No: Vol. 83, No. 3 (2017)
       
  • Immunotherapy in viral warts with intradermal Bacillus
           Calmette–Guerin vaccine versus intradermal tuberculin purified
           protein derivative: A double-blind, randomized controlled trial comparing
           effectiveness and safety in a tertiary care center in Eastern India

    • Authors: Indrashis Podder, Sabari Bhattacharya, Vivek Mishra, Tushar Kanti Sarkar, Somodyuti Chandra, Amrita Sil, Santasmita Pal, Dhiraj Kumar, Abanti Saha, Koushik Shome, Debabrata Bandyopadhyay, Nilay Kanti Das
      Pages: 411 - 411
      Abstract: Indrashis Podder, Sabari Bhattacharya, Vivek Mishra, Tushar Kanti Sarkar, Somodyuti Chandra, Amrita Sil, Santasmita Pal, Dhiraj Kumar, Abanti Saha, Koushik Shome, Debabrata Bandyopadhyay, Nilay Kanti Das
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):411-411
      Background: Current therapeutic modalities for viral warts are mostly ablative and are limited by high recurrence rates besides being unsuitable for numerous lesions. Immunotherapy has the potential to overcome these limitations.Aims: The aim of this study was to compare the effectiveness and safety of Bacillus Calmette–Guerin vaccine versus tuberculin purified protein derivative in the immunotherapy of warts.Methods: Patients received three doses of 0.1 ml of Bacillus Calmette–Guerin vaccine or tuberculin purified protein derivative intradermally over the deltoid region at 4-weekly intervals. They were followed-up for another month. Number of warts, complete cure rates and quality of life were assessed.Results: A total of 60 patients were included. Complete clearance was noted in 16 (48.5%) out of 33 patients in the Bacillus Calmette–Guerin group and in 5 (18.5%) out of 27 in the tuberculin purified protein derivative group (P = 0.121). The number of lesions reduced statistically significantly from baseline in both the groups (P < 0.001) from the first follow-up visit onward (P < 0.05). The reduction was statistically significantly more in the Bacillus Calmette–Guerin group than in the tuberculin purified protein derivative group from the second follow-up onward. Dermatologic life quality index improved statistically significantly with both treatments. Adverse events (pain during injection, abscess formation and scarring at injection site) were more frequent with Bacillus Calmette–Guerin. No recurrence was seen after lesions cleared.Limitations: Patients were not followed up for more than 4 weeks after treatment. We could not estimate the cytokine levels or the peripheral blood mononuclear cell proliferation in response to Bacillus Calmette–Guerin/tuberculin purified protein derivative injections.Conclusion: Both intradermal Bacillus Calmette–Guerin and tuberculin purified protein derivative hold promise in the treatment of viral warts. Bacillus Calmette–Guerin may be more effective, though it had more adverse events in our study.
      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):411-411
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.193623
      Issue No: Vol. 83, No. 3 (2017)
       
  • Giant, mutilating facial lupus vulgaris due to long-term misdiagnosis

    • Authors: Li Xue, Wei Li, Xiaoyan Lv, Li Li
      Pages: 412 - 412
      Abstract: Li Xue, Wei Li, Xiaoyan Lv, Li Li
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):412-412

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):412-412
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.186481
      Issue No: Vol. 83, No. 3 (2017)
       
  • A study of the efficacy of platelet-rich plasma in the treatment of
           androgenetic alopecia in males

    • Authors: Shruti Gupta, TN Revathi, S Sacchidanand, HV Nataraj
      Pages: 412 - 412
      Abstract: Shruti Gupta, TN Revathi, S Sacchidanand, HV Nataraj
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):412-412

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):412-412
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.191128
      Issue No: Vol. 83, No. 3 (2017)
       
  • Postsurgical pyoderma gangrenosum successfully treated with cyclosporine

    • Authors: Biswanath Behera, Laxmisha Chandrashekar, Devinder Mohan Thappa, Bheemanathi Hanuman Srinivas, Parth Pratim Pasayat, Ishita Laroiya
      Pages: 412 - 412
      Abstract: Biswanath Behera, Laxmisha Chandrashekar, Devinder Mohan Thappa, Bheemanathi Hanuman Srinivas, Parth Pratim Pasayat, Ishita Laroiya
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):412-412

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):412-412
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.193616
      Issue No: Vol. 83, No. 3 (2017)
       
  • Prof. K. Siddappa (1931&#8211;2017)

    • Authors: Arun C Inamadar
      Pages: 413 - 413
      Abstract: Arun C Inamadar
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):413-413

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):413-413
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/ijdvl.IJDVL_301_17
      Issue No: Vol. 83, No. 3 (2017)
       
  • Erratum: Digital volumetric measurement of cutaneous leishmaniasis
           lesions: Blur estimation method

    • Pages: 414 - 414
      Abstract:
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):414-414

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):414-414
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.205029
      Issue No: Vol. 83, No. 3 (2017)
       
  • Erratum: Clinical characteristics of acquired ungual fibrokeratoma

    • Pages: 414 - 414
      Abstract:
      Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):414-414

      Citation: Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):414-414
      PubDate: Mon,24 Apr 2017
      DOI: 10.4103/0378-6323.205030
      Issue No: Vol. 83, No. 3 (2017)
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.162.19.123
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016